A rigorous and credible evaluation approach is the bedrock of the selection process that selects the award
recipients for the most sought-after accolade in the industry.
Mumbai, India, August 24th 2011 –The prestigious independent panel of jury made up of leading Personages for the 2011 India Healthcare Excellence Awards has been officially announced. ALEXANDRIA REAL ESTATE EQUITIES, INC. has once again partnered with Frost & Sullivan for this year’s edition, which will be held in Mumbai on September 22nd 2011.
The Award methodology followed to determine best practices in the industry: Frost & Sullivan’s analyst team shortlists companies for each award category based on detailed research on market performance. Additionally,interviews are conducted with key personnel of shortlisted companies to substantiate, validate, and update information collected about each company.
The information on each company is then consolidated and a competitive matrix across 8-10 key parameters is prepared for judging. The key parameters are
• Revenue and Market Share Growth
• Proof of success in executing a restructuring strategy
• New market / product penetration / Unique Services / facilities / Innovative model
• Marketing, promotion and visibility of the company / customer education / value added services
• Evidence of success through strategy innovation / human resource initiatives
• Technological innovation and leadership
• Increased name recognition /awards
• Improvement in customer satisfaction and loyalty levels
The jury, drawing on the wealth of their individual experiences and detailed research conducted by Frost & Sullivan, will pick the most commendable award recipients and then mutually decide who will be the final recipients for the ‘Alexandria – Frost & Sullivan 2011 India Healthcare Excellence Awards’.
Announcing the event, Sandeep Sinha, Director, Healthcare Practice, South Asia and Middle East, Frost & Sullivan said “We are delighted to have such a great jury panel. We thank all of them for their rigorous involvement with us since the last one month, helping us in the selection of best of the best from the Indian healthcare industry. The jury processes are still in progress and will get over by end-August 2011. This year we have had over whelming response from variou healthcare companies across India.”
“My excellent experience being part of the Jury in 2010 and the apparent transparency in selecting the Best Performer in various categories convinced me to be part of the jury again this year. The list of finalists was limited, which indicated the detailed thought process that went into finalizing the lists for the jury to pick the winners. In my opinion the most important yardstick to judge a company is by return to shareholders and importance of innovation, a penchant to do things differently”, says, Mr. Daara B. Patel, Secretary General, Indian Drug Manufacturers’ Association.
The responsibility of choosing the award recipients has been entrusted to a group of individuals, each of them a leader and pioneer in their chosen field of work. The awards jury members who will pick the award recipients ahead of the awards ceremony on September 22nd 2011 are:
Abhay Pandey, Managing Director, Sequoia Capital India Advisors Pvt Ltd
AK Purwar, Chairman, IndiaVenture Advisors Private Limited
Alok Gupta, Managing Director – India, Partner, Headland Capital Partners (India) Private Limited
Dr. Arun Mullaji, Orthopaedic Surgeon, Kokilaben Dhirubhai Ambani Hospital
Dr. Chadha Manoj Dharam, Endocrinologist, Hinduja Hospital
Daara B Patel, Secretary General, Indian Drug Manufacturers Association
Dr. Jamshed J Dalal, Director, Cardiac Sciences, Kokilaben Dhirubhai Ambani Hospital
K Ramakrishnan, Executive Director & Head – Investment Banking, Spark Capital
Dr. Nilesh Shah, Chairman, NM Diagnostics
Dr. Prafulla G. Kerkar, HOD – Cardiology, KEM Hospital
R Basil, Ex President, Apollo Hospitals
Commander S Girish Kumar, Practice Head – Healthcare & Lifesciences, HP India
Srivathsan A, Managing Director, Healthways
Suresh N, Group Editor & Senior VP, BioSpectrum
Dr. Sunny Sharma, Senior Managing Director, OrbiMed Advisors, Asia
Dr Uday Patil, Senior Consultant – Radiology, Manipal Hospitals
Utkarsh Palnitkar, Executive Director, Centrum Capital Limited
Mr. Venkatadri Bobba, General Partner, VENTUREAST (VE)
Speaking of the Awards, Commander Girish Kumar, Practice Head – Healthcare and Lifesciences, HP India, said, “Hewlet Packard India takes pride in associating with Frost & Sullivan for recognizing the star players in the Healthcare eco system. While keeping the patient at the centre, there is a host of industry segments that work together to deliver quality care either curative or preventive. There is an element of selfless service beyond the business motives that keeps the various components of this eco system closely woven. The measurable objectives set forth in the evaluation and selection process makes it more scientific and transparent. I am privileged to be associated as a jury to select the better amongst the best in each of the categories.”
Hewlett-Packard referred, as HP is Gold partner for the prestigious Awards this year’s event. Asian Hospital and Healthcare Management, BioSpectrum, Hospital and Healthcare Management, Medical Buyer, Modern Medicare, Modern Pharmaceuticals, Pharmafocusasia.com are the media partners and ET Now is the official channel partner for the event.
To know more about this event please log on to www.frost.com/hcawards2011
About ALEXANDRIA REAL ESTATE EQUITIES, INC. (NYSE:ARE)
ALEXANDRIA REAL ESTATE EQUITIES, INC. (NYSE:ARE), Landlord of Choice to the Life Science Industry®, is the largestowner and pre-eminent real estate investment trust (“REIT”) focused principally on cluster development through the ownership, operation, management, selective redevelopment, development, and acquisition of properties containing life science laboratory space.
About Frost & Sullivan
Frost & Sullivan enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company’s Growth Partnership Service provides the CEO and the CEO’s Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. We leverage 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from over 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com
Corporate Communications – South Asia
P: +91.22.6607 2019
F: +91.22.2832 4713
Corporate Communications – South Asia, Middle East and North Africa
P: +91 98200 50519
F: +91 22 2832 4713